Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603 · see citing works

Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine

Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 954 · see citing works

Action of 2',2'-difluorodeoxycytidine on DNA synthesis.

Huang, P., Chubb, S., Hertel, L. W., Grindey, G. B., & Plunkett, W. K. (1991) · PubMed · Cited by 876 · see citing works

The purine path to chemotherapy

Elion, G. B. (1989) · Science · doi:10.1126/science.2649979 · Cited by 687 · see citing works

Capecitabine: A review

Walko, C. M., & Lindley, C. M. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.005 · Cited by 661 · see citing works

Mammalian deoxyribonucleoside kinases

Arnér, E. S. J., & Eriksson, S. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00015-9 · Cited by 581 · see citing works

Thymidylate synthetase - a target enzyme in cancer chemotherapy

Danenberg, P. V. (1977) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(77)90001-4 · Cited by 504 · see citing works

Metabolism and mechanism of action of 5-fluorouracil

Parker, W. B., & Cheng, Y. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90056-8 · Cited by 450 · see citing works

Gemcitabine: preclinical pharmacology and mechanisms of action.

Plunkett, W. K., Huang, P., Searcy, C. E., & Gandhi, V. V. (1996) · PubMed · Cited by 396 · see citing works

Structure and function of cellular deoxyribonucleoside kinases

Eriksson, S., Munch-Petersen, B., Johansson, K. S., et al. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8511-x · Cited by 295 · see citing works

Cellular and Clinical Pharmacology of Fludarabine

Gandhi, V. V., & Plunkett, W. K. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241020-00002 · Cited by 291 · see citing works

Ara-C: Cellular and Molecular Pharmacology

Grant, S. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60703-4 · Cited by 272 · see citing works

Discovery and development of clofarabine: a nucleoside analogue for treating cancer

Bonate, P. L., Arthaud, L. E., Cantrell, W. R. J., et al. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2055 · Cited by 259 · see citing works

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases

Rompay, A. R. V., Johansson, M., & Karlsson, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00048-6 · Cited by 244 · see citing works

Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine.

Nelson, J. A., Carpenter, J. W., Rose, L. M., et al. (1975) · PubMed · Cited by 244 · see citing works

Purine Nucleoside Phosphorylase Deficiency

Markert, M. L. (2012) · SpringerReference · doi:10.1007/springerreference_109893 · Cited by 240 · see citing works

Prodrug-activating systems in suicide gene therapy

Springer, C. J., & Niculescu‐Duvaz, I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10001 · Cited by 231 · see citing works

The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

Zhang, J., Visser, F., King, K. M., et al. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9044-4 · Cited by 231 · see citing works

Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity.

Huang, P., Chubb, S., & Plunkett, W. K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46267-3 · Cited by 210 · see citing works

Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.

Parker, W. B., Shaddix, S. C., Chang, C., et al. (1991) · PubMed · Cited by 209 · see citing works

Mechanisms of apoptosis induction by nucleoside analogs

Sampath, D., Rao, V. A., & Plunkett, W. K. (2003) · Oncogene · doi:10.1038/sj.onc.1207229 · Cited by 200 · see citing works

The pharmacology of the fluoropyrimidines.

Myers, C. E. (1981) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06848-6 · Cited by 191 · see citing works

Structure of human dCK suggests strategies to improve anticancer and antiviral therapy

Sabini, E., Ort, S., Monnerjahn, C., et al. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb942 · Cited by 184 · see citing works

Thiopurines, DNA damage, DNA repair and therapy-related cancer

Karran, P. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl020 · Cited by 182 · see citing works

Decitabine—Bedside to bench

Oki, Y., Aoki, E., & Issa, J. J. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.010 · Cited by 172 · see citing works

Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.

Carson, D. A., Wasson, D. B., Esparza, L. M., et al. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2970 · Cited by 159 · see citing works

The acyclic nucleoside phosphonates from inception to clinical use: Historical perspective

Clercq, E. D. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.10.006 · Cited by 155 · see citing works

Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders [published erratum appears in Blood 1996 Mar 1;87(5):2093]

Tallman, M., & Hakimian, D. (1995) · Blood · doi:10.1182/blood.v86.7.2463.2463 · Cited by 149 · see citing works

Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.

Parker, W. B., Bapat, A. R., Shen, J. X., et al. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09779-2 · Cited by 146 · see citing works

Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.

Grove, K. L., Guo, X., Liu, S., Gao, Z., Chu, C. K., & Cheng, Y.-T. (1995) · PubMed · Cited by 142 · see citing works

Prodrug cancer gene therapy

Altaner, Č. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.023 · Cited by 137 · see citing works

The clinical role of genetic polymorphisms in drug-metabolizing enzymes

Tomalik‐Scharte, D., Lazar, A., Fuhr, U., et al. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500462 · Cited by 136 · see citing works

Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine.

Xie, K. C., & Plunkett, W. K. (1996) · PubMed · Cited by 133 · see citing works

Thiopurine biology and pharmacology

Aarbakke, J., Janka-Schaub, G. E., & Elion, G. B. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01007-3 · Cited by 131 · see citing works

Prodrugs for Gene‐Directed Enzyme‐Prodrug Therapy (Suicide Gene Therapy)

Denny, W. A. (2003) · BioMed Research International · doi:10.1155/s1110724303209098 · Cited by 122 · see citing works

Metabolism and action of fludarabine phosphate.

Plunkett, W. K., Huang, P., & Gandhi, V. V. (1990) · PubMed · Cited by 117 · see citing works

Metabolism and Metabolic Actions of 6-Methylpurine and 2-Fluoroadenine in Human Cells

Parker, W. B., Allan, P. W., Shaddix, S. C., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00034-3 · Cited by 113 · see citing works

From bench to bedside for gene-directed enzyme prodrug therapy of cancer

Dachs, G. U., Tupper, J., & Tozer, G. M. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200504000-00001 · Cited by 113 · see citing works

A Novel Action of Human Apurinic/Apyrimidinic Endonuclease

Chou, K.-M., Kukhanova, M. K., & Cheng, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004082200 · Cited by 112 · see citing works

Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells.

Xie, C., & Plunkett, W. K. (1995) · PubMed · Cited by 107 · see citing works

Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase.

Bouchard, J., & Momparler, R. L. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14371-x · Cited by 102 · see citing works

Phosphorylation of Pyrimidine Deoxynucleoside Analog Diphosphates

Krishnan, P., Fu, Q., Lam, W., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109025200 · Cited by 97 · see citing works

Specificity of adenosine deaminase toward adenosine and 2′-deoxyadenosine analogues

Frederiksen, S. (1966) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(66)90202-5 · Cited by 95 · see citing works

Molecular, cellular and animal pharmacology of 5-AZA-2′-deoxycytidine

Momparler, R. L. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90053-1 · Cited by 94 · see citing works

The role of clofarabine in hematologic and solid malignancies—Development of a next‐generation nucleoside analog

Faderl, S. H., Gandhi, V. V., Keating, M. J., et al. (2005) · Cancer · doi:10.1002/cncr.21005 · Cited by 93 · see citing works

Selective toxicity of deoxyguanosine and arabinosyl guanine for T- leukemic cells

Cohen, A., Lee, J., & Gelfand, E. W. (1983) · Blood · doi:10.1182/blood.v61.4.660.660 · Cited by 92 · see citing works

L- and D-Enantiomers of 2′,3′-Dideoxycytidine 5′-Triphosphate Analogs as Substrates for Human DNA Polymerases

Kukhanova, M. K., Liu, S.-H., Mozzherin, D. J., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23055 · Cited by 90 · see citing works

Nucleosides and nucleotides. 100. 2'-C-Cyano-2'-deoxy-1-.beta.-D-arabinofuranosylcytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside

Matsuda, A., Nakajima, Y., Azuma, A., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00113a034 · Cited by 85 · see citing works

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine

Rodriguez, C. O., Stellrecht, C. M., & Gandhi, V. V. (2003) · Blood · doi:10.1182/blood-2003-01-0317 · Cited by 82 · see citing works

Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases.

Johansson, N. G., & Eriksson, S. (1996) · Acta Biochimica Polonica · doi:10.18388/abp.1996_4573 · Cited by 80 · see citing works

Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents

Schramm, V. L. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00073-x · Cited by 80 · see citing works

Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane-cytidine in human prostate carcinoma DU-145 cells.

Grove, K. L., & Cheng, Y. (1996) · PubMed · Cited by 78 · see citing works

Excision of 2',2'-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA.

Gandhi, V. V., Legha, J., Chen, F., et al. (1996) · PubMed · Cited by 77 · see citing works

Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.

Townsend, A. J., & Cheng, Y. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13007-1 · Cited by 77 · see citing works

Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.

Rodriguez, C. O., Mitchell, B. S., Ayres, M., et al. (2002) · PubMed · Cited by 74 · see citing works

Purine nucleoside phosphorylase: A target for drug design

Montgomery, J. A. J. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130302 · Cited by 72 · see citing works

Functions of Eukaryotic DNA Polymerases

Shcherbakova, P. V., Bębenek, K., & Kunkel, T. A. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.8.re3 · Cited by 69 · see citing works

Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts.

Shewach, D. S., Daddona, P. E., Ashcraft, E., et al. (1985) · PubMed · Cited by 68 · see citing works

Synthesis of 9-β-D-Arabinofuranosylguanine*

Reist, E. J., & Goodman, L. (1964) · Biochemistry · doi:10.1021/bi00889a004 · Cited by 63 · see citing works

Nelarabine: A novel purine antimetabolite antineoplastic agent

Buie, L. K., Epstein, S. S., & Lindley, C. M. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.002 · Cited by 60 · see citing works

A cohort study of oral contraceptive use and risk of benign breast disease

Rohan, T. E., & Miller, A. B. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990719)82:2 · Cited by 59 · see citing works

New antimetabolites in the treatment of human malignancies.

Cheson, B. D. (1992) · PubMed · Cited by 58 · see citing works

Excellent In vivo Bystander Activity of Fludarabine Phosphate against Human Glioma Xenografts that Express the Escherichia coli Purine Nucleoside Phosphorylase Gene

Hong, J. S., Waud, W. R., Levasseur, D. N., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0012 · Cited by 58 · see citing works

A method for the synchronization of cultured cells with aphidicolin: Application to the large-scale synchronization of L1210 cells and the study of the cell cycle regulation of thymidylate synthase and dihydrofolate reductase

Matherly, L. H., Schuetz, J. D., Westin, E. H., et al. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90605-2 · Cited by 56 · see citing works

Purine and pyrimidine nucleoside analogs.

Plunkett, W. K., & Gandhi, V. V. (2001) · PubMed · Cited by 56 · see citing works

Some comparative studies of calf and chicken adenosine deaminase

Chilson, O. P., & Fisher, J. R. (1963) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(63)90322-9 · Cited by 51 · see citing works

Preclinical Antitumor Activity of 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine (C1-F-Ara-A)

Waud, W. R., Schmid, S. M., Montgomery, J. A. J., et al. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033020 · Cited by 51 · see citing works

p53-Inducible Ribonucleotide Reductase ( p53R2/RRM2B ) Is a DNA Hypomethylation–Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia

Link, P. A., Baer, M. R., James, S. R., Jones, D. A., & Karpf, A. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1860 · Cited by 51 · see citing works

Novel Role of 3-Phosphoglycerate Kinase, a Glycolytic Enzyme, in the Activation of L-Nucleoside Analogs, a New Class of Anticancer and Antiviral Agents

Krishnan, P., Gullen, E. A., Lam, W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307052200 · Cited by 48 · see citing works

Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-β- d -arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma

Boyer, S. H., Sun, Z., Jiang, H., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0607449 · Cited by 44 · see citing works

Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cells.

Gandhi, V. V., Mineishi, S., Huang, P. H., et al. (1995) · PubMed · Cited by 41 · see citing works

Cladribine in the treatment of hairy-cell leukaemia

Goodman, G. R., Beutler, E., & Saven, A. (2003) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(02)00089-0 · Cited by 41 · see citing works

Utilization of 2'-deoxy-6-thioguanosine 5'-triphosphate in DNA synthesis in vitro by DNA polymerase alpha from calf thymus.

Yoshida, S., Yamada, M., Masaki, S., & Saneyoshi, M. (1979) · PubMed · Cited by 40 · see citing works

Polymerization of the triphosphates of AraC, 2′,2′-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase α and DNA primase

Richardson, K. A. K., Vega, T. P., Richardson, F. C., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.042 · Cited by 38 · see citing works

Metabolism of 4′-thio-β-d-arabinofuranosylcytosine in CEM cells

Parker, W. B., Shaddix, S. C., Rose, L. M., et al. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00520-7 · Cited by 35 · see citing works

Pharmacology and Mechanism of Action of Forodesine, a T-Cell Targeted Agent

Gandhi, V. V., & Balakrishnan, K. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.11.003 · Cited by 33 · see citing works

The Role of Human Nucleoside Transporters in Cellular Uptake of 4′-Thio-β-d-arabinofuranosylcytosine and β-d-Arabinosylcytosine

Clarke, M. L., Damaraju, V. L., Zhang, J., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021543 · Cited by 33 · see citing works

Three New Drugs for Acute Lymphoblastic Leukemia: Nelarabine, Clofarabine, and Forodesine

Larson, R. A. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.11.002 · Cited by 31 · see citing works

2′-Deoxy-6-Thioguanosine 5′-Triphosphate as a Substrate for Purified Human DNA Polymerases and Calf Thymus Terminal Deoxynucleotidyltransferase In Vitro

Ling, Y.-H., Nelson, J. A., Cheng, Y., Anderson, R. S., & Beattie, K. L. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15361-3 · Cited by 31 · see citing works

Nature and properties of mammalian ribonucleoside diphosphate reductase

Nutter, L. M., & Cheng, Y. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90016-0 · Cited by 30 · see citing works

Purine Nucleoside Phosphorylase Inhibition as a Novel Therapeutic Approach for B-Cell Lymphoid Malignancies

Furman, R. R., & Hoelzer, D. F. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.11.004 · Cited by 30 · see citing works

The role of DNA synthesis inhibition in the cytotoxicity of 2?,2?-difluoro-2?-deoxycytidine

Ostruszka, L. J., & Shewach, D. S. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0661-5 · Cited by 29 · see citing works

Preclinical antitumor activity of 4′-thio-β-d-arabinofuranosylcytosine (4′-thio-ara-C)

Waud, W. R., Gilbert, K. S., Shepherd, R. V., et al. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0589-9 · Cited by 28 · see citing works

Azapyrimidine nucleosides: metabolism and inhibitory mechanisms

Čihák, A., Veselý, J., & Sǩoda, J. (1985) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(85)90085-8 · Cited by 28 · see citing works

Hepatic Arterial Infusion of Chemotherapy for Hepatic Metastases from Colorectal Cancer

Homsi, J., & Garrett, C. R. (2006) · Cancer Control · doi:10.1177/107327480601300106 · Cited by 26 · see citing works

Metabolism and mechanism of action of 5-fluorodeoxycytidine.

Newman, E. M., & Santi, D. V. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6419 · Cited by 25 · see citing works

Repair of 2′- C -Cyano-2′-Deoxy-1-β- d - arabino -Pentofuranosylcytosine–Induced DNA Single-Strand Breaks by Transcription-Coupled Nucleotide Excision Repair

Wang, Y., Liu, X., Matsuda, A., & Plunkett, W. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6885 · Cited by 23 · see citing works

A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignancies

Gilbert, J., Carducci, M. A., Baker, S. D., et al. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-8219-0 · Cited by 20 · see citing works

Phosphorylation of 4′-thio-β-d-Arabinofuranosylcytosine and Its Analogs by Human Deoxycytidine Kinase

Someya, H., Shaddix, S. C., Tiwari, K. N., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045435 · Cited by 20 · see citing works

Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2′- C -cyano-2′-deoxy-1-β- d - arabino -pentofuranosylcytosine (CNDAC) 1 1Abbreviations: ara-C, ara-CMP, and ara-CTP, 1-β-d-arabinofuranosylcytosine and its 5′-mono- and triphosphate, respectively; CNDAC, CNDACMP, CNDACDP, and CNDACTP, 2′-C-cyano-2′-deoxy-1-β-d-arabino-pentofuranosylcytosine and its 5′-mono-, di-, and triphosphate, respectively; dNTP, deoxynucleoside triphosphate; CEM, CCRF-CEM human lymphoblastoid cells; and pol, DNA polymerase.

Azuma, A., Huang, P., Matsuda, A., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00617-7 · Cited by 17 · see citing works

Biochemical mechanisms of drug resistance. IX. Metabolic alterations in leukemic mouse cells following 5-aza-2'-deoxycytidine

Veselý, J., Čihák, A., & Šorm, F. (1969) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc19690901 · Cited by 17 · see citing works

Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEM

Takahashi, T., Shimizu, M., & Akinaga, S. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0472-0 · Cited by 17 · see citing works

Troxacitabine in acute leukemia

Swords, R. T., & Giles, F. J. (2007) · Hematology · doi:10.1080/10245330701406881 · Cited by 16 · see citing works

Long intracellular retention of 4′-thio-arabinofuranosylcytosine 5′-triphosphate as a critical factor for the anti-solid tumor activity of 4′-thio-arabinofuranosylcytosine

Someya, H., Waud, W. R., & Parker, W. B. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0126-0 · Cited by 14 · see citing works

Forodesine Treatment and Post-Transplant Graft-Versus-Host Disease in Two Patients With Acute Leukemia: Facilitation of Graft-Versus-Leukemia Effect?

Gore, L., Stelljes, M., & Quinones, R. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.11.005 · Cited by 10 · see citing works

A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group

Goss, G. D., Siu, L. L., Gauthier, I., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0201-1 · Cited by 9 · see citing works

A Phase I Study of a New Nucleoside Analogue, OSI-7836, Using Two Administration Schedules in Patients with Advanced Solid Malignancies

Lee, C. P., de Jonge, M. J. A., O'Donnell, A. E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1932 · Cited by 8 · see citing works

Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors

Richardson, F. C., Black, C., Richardson, K., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0844-8 · Cited by 7 · see citing works

Hungry for Science

Chen, I. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.1.nf1 · Cited by 3 · see citing works

Targeting Metabolism for Cancer Therapy

Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works

Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer

Halbrook, C. J., Pontious, C., Kovalenko, I., Lapienyte, L., Dreyer, S., Lee, H.-J., Thurston, G., Zhang, Y., Lazarus, J., Sajjakulnukit, P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.001 · Cited by 419 · see citing works

Macropinocytosis confers resistance to therapies targeting cancer anabolism

Jayashankar, V., & Edinger, A. L. (2020) · Nature Communications · doi:10.1038/s41467-020-14928-3 · Cited by 200 · see citing works

Enhancing autophagy in Alzheimer's disease through drug repositioning

Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89 · see citing works

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

A Research on Citation Standard

Fang-zhon, L. (2013) · Journal of Sichuan University of Science & Engineering

Citation Form in Transition: The ALWD Citation Manual

Rainwater, V. (2000) · Texas A&M Law Review · doi:10.37419/twlr.v7.i1.2

The Evolution of Principia Mathematica; Bertrand Russell's Manuscripts and Notes for the Second Edition

Landini, G. (2013) · History and Philosophy of Logic · doi:10.1080/01445340.2012.743288 · Cited by 1 · see citing works

Citation Managers

Jopson, B. (1998) · Optics and Photonics News · doi:10.1364/opn.9.9.000058